Status:
COMPLETED
Association Between Erythroferron and Perioperative Hemoglobin Levels in Patient Undergoing Heart Valve Surgery
Lead Sponsor:
Yonsei University
Conditions:
Postoperative Anemia
Eligibility:
All Genders
20+ years
Brief Summary
In patients undergoing cardiac surgery, perioperative anemia is an important factor in surgical recovery. In addition to the low preoperative hemoglobin level, the delayed recovery of the postoperativ...
Eligibility Criteria
Inclusion
- Patients older than 20 years
- undergoing elective valvular heart surgery
Exclusion
- Emergency operation
- Co-operation with other surgeries
- Patients with cardiogenic shock or ventricular-assist device (eg. ECMO, IABP)
- Patients requiring mechanical ventilator care in preoperative period
- Patient with severe chronic kidney disease (GFR(CKD-EPI) \<30ml/min/1.73m2)
- Patients with preoperative infection status (Eg. Sepsis)
- Patients with acute bleeding status
- Hemoglobin concentration below 10g/dL
- Disease directly affecting hematopoiesis (eg. Leukemia, myeloma, aplastic anemia)
- Uncompensated liver cirrhosis, acute hepatitis, alcoholics
- Patients who participated in other clinical studies that could affect prognosis
- Patients who cannot understand the informed consent (eg. Foreigner)
Key Trial Info
Start Date :
June 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 15 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05384054
Start Date
June 23 2022
End Date
September 15 2025
Last Update
October 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei University Health System, Severance Hospital
Seoul, South Korea